Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer
Yoshikazu Johmura(Kanazawa University), Makoto Nakanishi(The Cancer Institute Hospital)
Cited by 75
Related Papers
NAK is an IκB kinase-activating kinase
|Nature|2000|374
Response to DNA damage: why do we need to focus on protein phosphatases?
|Frontiers in Oncology|2013|36
Vaccine Therapy for Heart Failure Targeting the Inflammatory Cytokine Igfbp7
|Circulation|2024|35